Dalena Tran

Array ( [id] => 1417947 [patent_doc_number] => 06518278 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same' [patent_app_type] => B1 [patent_app_number] => 09/496603 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 8750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518278.pdf [firstpage_image] =>[orig_patent_app_number] => 09496603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337972 [patent_doc_number] => 06593353 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'p53 inhibitors and therapeutic use of the same' [patent_app_type] => B1 [patent_app_number] => 09/493527 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 10884 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593353.pdf [firstpage_image] =>[orig_patent_app_number] => 09493527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1355768 [patent_doc_number] => 06576621 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Preparation of thioarabinofuranosyl compounds and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/493247 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8540 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576621.pdf [firstpage_image] =>[orig_patent_app_number] => 09493247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669527 [patent_doc_number] => 20030114511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties' [patent_app_type] => new [patent_app_number] => 09/492531 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3067 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114511.pdf [firstpage_image] =>[orig_patent_app_number] => 09492531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305406 [patent_doc_number] => 06326376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Anhydrovinblastine for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 9/380540 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 9000 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326376.pdf [firstpage_image] =>[orig_patent_app_number] => 380540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495702 [patent_doc_number] => 06403634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Use of taxoid derivatives' [patent_app_type] => B1 [patent_app_number] => 09/482015 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4552 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 509 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403634.pdf [firstpage_image] =>[orig_patent_app_number] => 09482015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514803 [patent_doc_number] => 06420371 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies' [patent_app_type] => B1 [patent_app_number] => 09/479660 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 28 [patent_no_of_words] => 8212 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420371.pdf [firstpage_image] =>[orig_patent_app_number] => 09479660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545767 [patent_doc_number] => 06444658 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Prevention of ovarian cancer by administration of a vitamin D compound' [patent_app_type] => B1 [patent_app_number] => 09/479021 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444658.pdf [firstpage_image] =>[orig_patent_app_number] => 09479021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470190 [patent_doc_number] => 06407082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Prevention of ovarian cancer by administration of a vitamin D compound' [patent_app_type] => B1 [patent_app_number] => 09/479837 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7541 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407082.pdf [firstpage_image] =>[orig_patent_app_number] => 09479837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494529 [patent_doc_number] => 06342490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Pharmaceutical composition containing uscharidin or its analogues' [patent_app_type] => B1 [patent_app_number] => 09/423358 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 57 [patent_no_of_words] => 3971 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342490.pdf [firstpage_image] =>[orig_patent_app_number] => 09423358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814287 [patent_doc_number] => 20030073837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => '3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY' [patent_app_type] => new [patent_app_number] => 09/476232 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36865 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073837.pdf [firstpage_image] =>[orig_patent_app_number] => 09476232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410636 [patent_doc_number] => 06228876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Pharmaceutical composition for inhibiting the growth of cancers' [patent_app_type] => 1 [patent_app_number] => 9/469389 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2999 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228876.pdf [firstpage_image] =>[orig_patent_app_number] => 469389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409739 [patent_doc_number] => 06310054 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Prevention of ovarian cancer by administration of progestin products' [patent_app_type] => 1 [patent_app_number] => 9/464899 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7735 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310054.pdf [firstpage_image] =>[orig_patent_app_number] => 464899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304191 [patent_doc_number] => 06251886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Methods of using temozolomide in the treatment of cancers' [patent_app_type] => 1 [patent_app_number] => 9/453747 [patent_app_country] => US [patent_app_date] => 1999-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6872 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251886.pdf [firstpage_image] =>[orig_patent_app_number] => 453747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373955 [patent_doc_number] => 06562830 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/436806 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8880 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562830.pdf [firstpage_image] =>[orig_patent_app_number] => 09436806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349761 [patent_doc_number] => 06214803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Pharmacological composition for treating cancer cells' [patent_app_type] => 1 [patent_app_number] => 9/435521 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 4943 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214803.pdf [firstpage_image] =>[orig_patent_app_number] => 435521 [rel_patent_id] =>[rel_patent_doc_number] =>)